Posted in Regulatory Telomir seeks FDA approval for Telomir-1 to treat breast cancer April 1, 2026 Pharmaceutical Technology Telomir Pharmaceuticals has submitted an IND application to the FDA for Telomir-1, its lead candidate targeting advanced and metastatic TNBC. RegulatoryOncologyRead full story